Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all
Page 1
NOX2: is the best defense a good offense?
Zhang WX, Kubes P. Zhang WX, et al. Blood. 2022 May 12;139(19):2851-2853. doi: 10.1182/blood.2022016192. Blood. 2022. PMID: 35552646 No abstract available.
Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT.
Kanack A, Bayas A, George G, Abou-Ismail MY, Singh B, Kohlhagen M, Splinter N, Christ M, Naumann M, Moser KA, Smock KJ, Grazioli A, Wen R, Wang D, Murray DL, Padmanabhan A. Kanack A, et al. Blood. 2022 May 13:blood.2021014588. doi: 10.1182/blood.2021014588. Online ahead of print. Blood. 2022. PMID: 35560046
MRD in multiple myeloma: does CR really matter?
Paiva B, San-Miguel JF, Avet-Loiseau H. Paiva B, et al. Blood. 2022 May 13:blood.2022016170. doi: 10.1182/blood.2022016170. Online ahead of print. Blood. 2022. PMID: 35560160
Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL.
Diorio C, Murray R, Naniong M, Barrera LA, Camblin AJ, Chukinas JA, Coholan L, Edwards A, Fuller T, Gonzales C, Grupp SA, Ladd AM, Le MB, Messana A, Musenge F, Newman H, Poh YC, Poulin H, Ryan T, Shraim R, Tasian SK, Vincent TL, Young L, Zhang Y, Ciaramella G, Gehrke J, Teachey DT. Diorio C, et al. Blood. 2022 May 13:blood.2022015825. doi: 10.1182/blood.2022015825. Online ahead of print. Blood. 2022. PMID: 35560156